Effects of lysophosphatidic acid and its receptors LPA1/3 on radiation pneumonitis

Oncology Reports

Volumn 24, Issue 6, 2010, Pages 1515-1520

  Xue, Jianxin ^a   Gan, Lu ^b   Li, Xin ^a   Li, Jian ^c   Qi, Guohai ^c   Wu, Yalan ^a   Fu, Xiaoyue ^a   Mao, Qing ^a   Ao, Rui ^a   Lang, Jingyi ^c   Lu, You ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN CANCER HOSPITAL   (China)

Author keywords

Lysophosphatidic acid; Lysophosphatidic acid receptor; Radiation pneumonitis; VPC 12249

Indexed keywords

BETA ACTIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; LYSOPHOSPHATIDIC ACID RECEPTOR 3; MALONALDEHYDE; RECEPTOR BLOCKING AGENT; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VPC 12249;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; CTGF GENE; DOSE RESPONSE; FEMALE; GENE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIATION PNEUMONIA; TGF B1 GENE;

ANIMALS; CONNECTIVE TISSUE GROWTH FACTOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FEMALE; I-KAPPA B KINASE; LUNG; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED C57BL; OLEIC ACIDS; PHOSPHORIC ACID ESTERS; PHOSPHORYLATION; RADIATION PNEUMONITIS; RADIATION-PROTECTIVE AGENTS; RECEPTORS, LYSOPHOSPHATIDIC ACID; TRANSFORMING GROWTH FACTOR BETA1;

EID: 78649422056     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00001013     Document Type: Article

References (31)

1. Haiping Z, Takayama K, Uchino J, et al: Prevention of radiation-induced pneumonitis by recombinant adenovirus-mediated transferring of soluble TGF-beta type II receptor gene. Cancer Gene Ther 13: 864-872, 2006.
2. Tsoutsou PG and Koukourakis MI: Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 66: 1281-1293, 2006.
3. Para AE, Bezjak A, Yeung IW, Van Dyk J and Hill RP: Effects of genistein following fractionated lung irradiation in mice. Radiother Oncol 92: 500-510, 2009.
4. Yuan X, Liao Z, Liu Z, et al: Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy. J Clin Oncol 27: 3370-3378, 2009.
5. Zhao L, Wang L, Ji W, et al: Elevation of plasma TGF-beta1 during radiation therapy predicts radiation-induced lung toxicity in patients with non-small-cell lung cancer: a combined analysis from Beijing and Michigan. Int J Radiat Oncol Biol Phys 74: 1385-1390, 2009.
6. Noguchi K, Herr D, Mutoh T and Chun J: Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 9: 15-23, 2009.
7. Tokumura A: Metabolic pathways and physiological and pathological significances of lysolipid phosphate mediators. J Cell Biochem 92: 869-881, 2004.
8. Choi JW, Herr DR, Noguchi K, et al: LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 50: 157-186, 2010.
9. Barekzi E, Roman J, Hise K, Georas S and Steinke JW: Lysophosphatidic acid stimulates inflammatory cascade in airway epithelial cells. Prostaglandins Leukot Essent Fatty Acids 74: 357-363, 2006.
10. Lin CI, Chen CN, Lin PW, Chang KJ, Hsieh FJ and Lee H: Lysophosphatidic acid regulates inflammation-related genes in human endothelial cells through LPA1 and LPA3. Biochem Biophys Res Commun 363: 1001-1008, 2007.
11. Georas SN, Berdyshev E, Hubbard W, et al: Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge. Clin Exp Allergy 37: 311-322, 2007.
12. Tager AM, LaCamera P, Shea BS, et al: The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 14: 45-54, 2008.
13. Ley K and Zarbock A: From lung injury to fibrosis. Nat Med 14: 20-21, 2008.
14. Rabbani ZN, Anscher MS, Zhang X, Chen L, Samulski TV, Li CY and Vujaskovic Z: Soluble TGFbeta type II receptor gene therapy ameliorates acute radiation-induced pulmonary injury in rats. Int J Radiat Oncol Biol Phys 57: 563-572, 2003.
15. Zhao Y and Natarajan V: Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling. Cell Signal 21: 367-377, 2009.
16. Aoki J, Taira A, Takanezawa Y, et al: Serum lysophosphatidic acid is produced through diverse phospholipase pathways. J Biol Chem 277: 48737-48744, 2002. (Pubitemid 35470839)
17. Westermann AM, Havik E, Postma FR, Beijnen JH, Dalesio O, Moolenaar WH and Rodenhuis S: Malignant effusions contain lysophosphatidic acid (LPA)-like activity. Ann Oncol 9: 437-442, 1998.
18. Pradere JP, Klein J, Gres S, et al: LPA1 receptor activation promotes renal interstitial fibrosis. J Am Soc Nephrol 18: 3110-3118, 2007.
19. Okusa MD, Ye H, Huang L, Sigismund L, Macdonald T and Lynch KR: Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 285: F565-F574, 2003.
20. Fleckenstein K, Gauter-Fleckenstein B, Jackson IL, Rabbani Z, Anscher M and Vujaskovic Z: Using biological markers to predict risk of radiation injury. Semin Radiat Oncol 17: 89-98, 2007.
21. Kang SK, Rabbani ZN, Folz RJ, et al: Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury. Int J Radiat Oncol Biol Phys 57: 1056-1066, 2003.
22. Holtsberg FW, Steiner MR, Bruce-Keller AJ, Keller JN, Mattson MP, Moyers JC and Steiner SM: Lysophosphatidic acid and apoptosis of nerve growth factor-differentiated PC12 cells. J Neurosci Res 53: 685-696, 1998. (Pubitemid 28423877)
23. Hashimoto T, Yamashita M, Ohata H and Momose K: Lysophosphatidic acid enhances in vivo infiltration and activation of guinea pig eosinophils and neutrophils via a Rho/Rho-associated protein kinase-mediated pathway. J Pharmacol Sci 91: 8-14, 2003.
24. Lin CI, Chen CN, Chen JH and Lee H: Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism. J Cell Biochem 99: 1216-1232, 2006.
25. Rube CE, Palm J, Erren M, Fleckenstein J, Konig J, Remberger K and Rube C: Cytokine plasma levels: reliable predictors for radiation pneumonitis. PLoS One 3: e2898, 2008.
26. Chen MF, Keng PC, Lin PY, Yang CT, Liao SK and Chen WC: Caffeic acid phenethyl ester decreases acute pneumonitis after irradiation in vitro and in vivo. BMC Cancer 5: 158, 2005.
27. Andarawewa KL, Paupert J, Pal A and Barcellos-Hoff MH: New rationales for using TGFbeta inhibitors in radiotherapy. Int J Radiat Biol 83: 803-811, 2007.
28. Vallabhapurapu S and Karin M: Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol 27: 693-733, 2009.
29. Zhao Y, Usatyuk PV, Cummings R, et al: Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells. Biochem J 385: 493-502, 2005.
30. Saatian B, Zhao Y, He D, Georas SN, Watkins T, Spannhake EW and Natarajan V: Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells. Biochem J 393: 657-668, 2006.
31. Sun J and Lin X: Beta-arrestin 2 is required for lysophosphatidic acid-induced NF-kappaB activation. Proc Natl Acad Sci USA 105: 17085-17090, 2008.